Business Description
Synthetic MR AB
ISIN : SE0015987946
Total Employee Number:
40Compare
Compare
Traded in other countries / regions
SYNT.Sweden9480.Germany0G79.UKSYNMF.USA IPO Date
2013-10-18Description
Synthetic MR AB develops and markets software solutions that improve the efficiency of neuroimaging processes and diagnostic accuracy. SyntheticMR's SyMRI solution measures the brain's absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single rapid examination. Combinostics offers the AI-driven cNeuro product family, which helps clinicians make a difference in the lives of patients with neurological diseases. Geographically, the group operates in America, Europe, and APAC. The majority of its revenue is generated from Europe.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.69 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.59 | |||||
Beneish M-Score | -3.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -14.7 | |||||
3-Year FCF Growth Rate | 27.1 | |||||
3-Year Book Growth Rate | -9.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 49.52 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.27 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.9 | |||||
9-Day RSI | 42.24 | |||||
14-Day RSI | 41.03 | |||||
3-1 Month Momentum % | -22.58 | |||||
6-1 Month Momentum % | -41.34 | |||||
12-1 Month Momentum % | -75.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.04 | |||||
Quick Ratio | 3.04 | |||||
Cash Ratio | 1.21 | |||||
Days Sales Outstanding | 117.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -60.31 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 111.22 | |||||
Operating Margin % | -81.12 | |||||
Net Margin % | -85.55 | |||||
EBITDA Margin % | -59.44 | |||||
FCF Margin % | -31.41 | |||||
OCF Margin % | -18.53 | |||||
ROE % | -38.37 | |||||
ROA % | -29.5 | |||||
ROIC % | -32.65 | |||||
3-Year ROIIC % | -126.02 | |||||
ROC (Joel Greenblatt) % | -1566.69 | |||||
ROCE % | -34.23 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 266.67 | |||||
PS Ratio | 0.7 | |||||
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 1.01 | |||||
EV-to-EBIT | -0.49 | |||||
EV-to-Forward-EBIT | -1.6 | |||||
EV-to-EBITDA | -0.66 | |||||
EV-to-Forward-EBITDA | -3.21 | |||||
EV-to-Revenue | 0.39 | |||||
EV-to-Forward-Revenue | 0.61 | |||||
EV-to-FCF | -1.22 | |||||
Price-to-GF-Value | 0.13 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
| Price-to-Net-Current-Asset-Value | 1.06 | |||||
| Price-to-Net-Cash | 30.8 | |||||
Earnings Yield (Greenblatt) % | -205.88 | |||||
FCF Yield % | -31.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synthetic MR AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 55.895 | ||
| EPS (TTM) (kr) | -0.739 | ||
| Beta | 0.8471 | ||
| 3-Year Sharpe Ratio | -1.67 | ||
| 3-Year Sortino Ratio | -1.62 | ||
| Volatility % | 56.36 | ||
| 14-Day RSI | 41.03 | ||
| 14-Day ATR (kr) | 0.055618 | ||
| 20-Day SMA (kr) | 0.6379 | ||
| 12-1 Month Momentum % | -75.6 | ||
| 52-Week Range (kr) | 0.58 - 3.9 | ||
| Shares Outstanding (Mil) | 89.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synthetic MR AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synthetic MR AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-25 | In 134 days | ||
| Second quarter earnings results for 2026 | 2026-08-25 | In 42 days | ||
| General meeting for 2025 | 2026-05-27 18:00 | 0.77 (-14.03%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 1.08 (+0.93%) | ||
| Annual report for 2025 | 2026-04-09 | 0.95 (-4.83%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-06 | 1.12 (-8.20%) | ||
| Third quarter earnings results for 2025 | 2025-11-28 | 1.62 (-1.69%) | ||
| Second quarter earnings results for 2025 | 2025-08-26 | 3.30 (-1.11%) | ||
| General meeting for 2024 | 2025-05-20 18:00 | 3.85 (+4.53%) | ||
| First quarter earnings results for 2025 | 2025-05-20 | 3.85 (+4.53%) |
Show
Entries
Synthetic MR AB Frequently Asked Questions
What is Synthetic MR AB(XSAT:SYNT)'s stock price today?
The current price of XSAT:SYNT is kr0.62. The 52 week high of XSAT:SYNT is kr3.90 and 52 week low is kr0.58.
When is next earnings date of Synthetic MR AB(XSAT:SYNT)?
The next earnings date of Synthetic MR AB(XSAT:SYNT) is 2026-08-25.
Does Synthetic MR AB(XSAT:SYNT) pay dividends? If so, how much?
Synthetic MR AB(XSAT:SYNT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Synthetic MR AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers